Scarica l'app Stockscreener
1.06
0.00%
0.00
Dopo l'orario di chiusura:
1.06
Precedente Chiudi:
$1.06
Aprire:
$1.0746
Volume 24 ore:
19,227
Relative Volume:
0.59
Capitalizzazione di mercato:
$24.71M
Reddito:
-
Utile/perdita netta:
$-10.23M
Rapporto P/E:
-1.0095
EPS:
-1.05
Flusso di cassa netto:
$-10.26M
1 W Prestazione:
+2.91%
1M Prestazione:
+3.92%
6M Prestazione:
-20.90%
1 anno Prestazione:
-20.30%
Intervallo 1D:
$1.01
$1.08
Intervallo di 1 settimana:
$0.98
$1.13
Portata 52W:
$0.5306
$2.35
Renovorx Inc Stock (RNXT) Company Profile
Nome
Renovorx Inc
Settore
Industria
Telefono
408-800-2649
Indirizzo
333 W. SANTA CLARA STREET, SUITE 900, SAN JOSE
Renovorx Inc Borsa (RNXT) Ultime notizie
We Think RenovoRx (NASDAQ:RNXT) Needs To Drive Business Growth Carefully - Yahoo Finance
RenovoRx ramps up production of RenovoCath system By Investing.com - Investing.com South Africa
RenovoRx ramps up production of RenovoCath system - Investing.com
RenovoRx ramps up production of RenovoCath system By Investing.com - Investing.com UK
RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians - GlobeNewswire
RenovoRx Increases Production of FDA-Cleared RenovoCath® Delivery System in Response to Strong Demand from Oncology and Interventional Radiology Physicians - StockTitan
Rhumbline Advisers Has $1.23 Million Stock Holdings in The RMR Group Inc. (NASDAQ:RMR) - Defense World
Renovos Biologics Appoints New Non-Executive Director - European Pharmaceutical Manufacturer
RXO Inc (RXO) Shares Up 4.51% on Sep 19 - GuruFocus.com
RenovoRx Announces Presentation at Symposium on Clinical Interventional Oncology Highlighting TAMP™ for Targeted Treatment of Locally Advanced Pancreatic Cancer - StockTitan
State of New Jersey Common Pension Fund D Has $2.48 Million Stock Position in RXO, Inc. (NYSE:RXO) - Defense World
Jefferies initates Ralph Lauren Corp (RL) stock to a Buy - Knox Daily
Reckitt shares up on report of potential homecare asset sale By Investing.com - Investing.com Australia
Reckitt starts talks on $7.9 bln homecare assets sale, Bloomberg News reports - XM
Federated Hermes Inc. Boosts Stock Position in The RMR Group Inc. (NASDAQ:RMR) - Defense World
Ascendiant Capital Markets Increases RenovoRx (NASDAQ:RNXT) Price Target to $8.25 - Defense World
RenovoRx (NASDAQ:RNXT) Trading Up 1.7% - Defense World
What was RenovoRx Inc (RNXT)’s performance in the last session? - US Post News
The time has not yet come to remove your chips from the table: RenovoRx Inc (RNXT) - SETE News
RenovoRx CEO Shaun Bagai to Present at H.C. Wainwright’s 26th Annual Global Investment Conference on September 9, 2024 in New York - StockTitan
RNXT Stock Earnings: RenovoRx Meets EPS for Q2 2024 - MSN
RenovoRx (NASDAQ:RNXT) Releases Quarterly Earnings Results - Defense World
RenovoRx continues drug-device combo Phase III trial in pancreatic cancer - Yahoo Finance
RenovoRx Announces First Patient Enrolled at University of Nebraska Medical Center for the Ongoing Pivotal Phase III TIGeR-PaC Clinical Trial - StockTitan
RNXT Stock Earnings: RenovoRx Meets EPS for Q2 2024 - InvestorPlace
RenovoRx, Inc. - Stocks Telegraph
TAMP therapy shows promise in pancreatic cancer survival By Investing.com - Investing.com Nigeria
TAMP therapy shows promise in pancreatic cancer survival - Investing.com
RenovoRx Announces Publication of Positive Early-Stage Clinical Data in International Peer-Reviewed Journal, The Oncologist® - StockTitan
UNMC joins trial exploring new pancreatic cancer treatment - University of Nebraska Medical Center
Nektar Therapeutics (NASDAQ:NKTR) vs. RenovoRx (NASDAQ:RNXT) Critical Comparison - Defense World
RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The Oncologist® - StockTitan
RenovoRx Announces Publication Of Results Of Pre-Clinical Studies Support Efficacy And Drug Delivery Mechanism ... - Quantisnow
RenovoRx CEO Updates Shareholder Letter - Quantisnow
University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx's Pivotal Phase III TIGeR-PaC ... - StockTitan
RenovoRx Inc (RNXT) deserves closer scrutiny – US Post News - US Post News
RenovoRx (NASDAQ:RNXT) Coverage Initiated by Analysts at Ascendiant Capital Markets - Defense World
Ascendiant Capital highlights cancer therapy, sees potential on RenovoRx stock - Investing.com India
Ascendiant Capital highlights cancer therapy, sees potential on RenovoRx stock By Investing.com - Investing.com Australia
Ascendiant Capital highlights cancer therapy, sees potential on RenovoRx stock By Investing.com - Investing.com
Analyzing Verrica Pharmaceuticals (NASDAQ:VRCA) and RenovoRx (NASDAQ:RNXT) - Defense World
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Benzinga
RenovoRx appoints new SVP to bolster strategy By Investing.com - Investing.com
RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships - StockTitan
RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships - GlobeNewswire Inc.
RenovoRx appoints new SVP to bolster strategy - Investing.com India
RenovoRx announces $5M registered direct offering priced at-the-marketTipRanks.com - TipRanks
RenovoRx, Inc. (NASDAQ:RNXT) Short Interest Up 28.9% in May - Defense World
RenovoRx (RNXT) Stock Price, News & Analysis - MarketBeat
RenovoRx Announces Presentations at the Advanced Interventional Management Symposium (AIMsymposium) Highlighting its Innovative RenovoTAMP® Therapy Platform for Targeted Treatment of Cancers - Quantisnow
RenovoRx raises $17.2 million to advance cancer trialInvesting.com ZA - Investing.com South Africa
Renovorx Inc Azioni (RNXT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.05%
4.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):